Latest news
02 March 2023
Access European Urology Today: EAU23 Congress Edition
16 February 2023
Videos: Hints and tricks for presenters
If you’re presenting an abstract at EAU23, why not prepare yourself with these three short videos by our expert on
23 January 2023
Dive back into learning: Join EAU23’s dynamic mix of educational activities
Optimal learning involves more than active listening. Enjoy and benefit from a well-rounded (and fun) educational experience at EAU23. Expect
15 January 2023
Get crucial updates and skills-building on patient engagement
The EAU Patient Office is currently preparing for its major annual event, the EAU Patient Day. Since its inception, the
12 January 2023
A new approach to Live Surgery at EAU23
There will be a new approach to live surgery at EAU23, as the Scientific Congress Office is more directly involved
10 January 2023
What’s on the agenda for young urologists at EAU23?
There is a fascinating programme planned for this year’s edition of YUORDay which will take place on Saturday, 11 March
15 December 2022
EAU23: The Big Scientific Programme Preview
On 10-13 March 2023, Milan will host one of the world’s largest urology events. Over 4500 abstracts were submitted for
25 November 2022
EAU23: Abstract submission numbers for Milan back to normal
Submissions came in from all over the world After two years of lower abstract submission numbers, it looks like the
22 November 2022
History Congress to offer “inspiration and perspective”
The EAU History Office is hosting another edition of the International Congress on the History of Urology to coincide with
10 July 2022
Liquid biomarkers: What do we expect in the future?
Chaired by Prof. Lars Dyrskjøt (DK) and Prof. Arnulf Stenzl (DE), Plenary Session 7 was full of rapid-fire debate reviewing
04 July 2022
Liquid Biomarkers in oncology
04 July 2022
EAUTV: The role of lasers in Stone treatment
04 July 2022
All facets of stone surgery covered at Plenary Session 8
Current cystinuria research is focused on methods of monitoring disease activity, as well as novel drug therapies and genotype-phenotype studies.